Skip To Main Content
Luisa Freyer on Muck Rack

Luisa Freyer

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Luisa Freyer’s profile

Articles by Luisa Freyer

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial

|
By Konstantinos D. Rizas, Konstantinos Mourouzis, Dominik Rath, Christoph B. Olivier, Theofanis Korovesis, Amin Polzin, Amani Al Tawil, Reza Wakili, Katharina Mayer, Sarah Lang, Sebastian Maier, Lorenz Bott-Flügel, Harilaos Bogossian, Konstantinos E Iliodromitis, Julius Steffen, Elodie Eiffener, Lauren Sams Verified, Tobias Petzold, Axel Linke, Felix M. Heidrich, Saif Zako, Andreas Schäfer, Frank Edelmann, David Leistner, Fabian Knebel, Georg Nickenig, Blerim Luani, Tienush Rassaf, Hüseyin Ince Verified, Ibrahim Akin, Micha T. Maeder, Meinrad Gawaz, Hans-Josef Feistritzer, Norbert Frey, Stefan Kääb, Matthias Pauschinger, Thomas Stiermaier, Ingo Eitel, Jan Wolter, Michael Schreinlechner, Axel Bauer, Christoph Stellbrink, Ulf Landmesser, Paulus Kirchhof, Dirk Sibbing, Holger Thiele, Adnan Kastrati, Ulrich Mansmann, Steffen Massberg, Lukas von Stuelpnagel, Marion Janisch, Tanja Ulrich, Florian Brattinger, Luisa Freyer, Samuel Sossala, Nikolaos Dagkonakis, Mariya Maslarska, Riza Sahin, Marc Kollum
| Nature Verified
Abstract The selection of the optimal antithrombotic regimen in patients with atrial fibrillation and acute coronary syndrome remains challenging. Previous trials have demonstrated that dual antithrombotic therapy (DAT), consisting of direct oral anticoagulants (DOACs) plus a P2Y12 inhibitor, reduces bleeding compared to a triple-therapy regimen using vitamin K antagonists.
Open in Who Shared Issue with article?
Show More